Jonathan Kfoury is a Partner Emeritus in L.E.K. Consulting’s Chicago office, focused on life sciences and healthcare. He joined the firm in 2006 and has led an extensive set of engagements with global biopharmaceutical, medical technology and healthcare/health system clients, as well as emerging and leading non-profit organizations focused in global health and access. Jonathan advises clients on commercial strategy, R&D planning, organizational scale-up and growth / partnering strategy.

Among extensive broader experience in oncology, immunology, neurology and rare diseases, Jonathan has been active in the infectious disease space for over 15 years. In particular, Jonathan has published and spoken extensively across the industry on the crisis of antimicrobial resistance, barriers to investment into novel antibiotics, public/private partnership and key opportunities for innovators within anti-infectives more broadly.

In 2019, Jonathan Kfoury was named a board member to the Bay Area Global Health Alliance – a network of over 100 leading organizations across a spectrum of sectors focused on strengthening the Bay Area’s global health impact worldwide, as well as driving economic impact in the region. Prior to joining L.E.K., Jonathan was a Business Development executive at several biopharma organizations, and manager of global Clinical Development for Cubist Pharmaceuticals’ (now Merck) blockbuster antibiotic Cubicin® – the most successful IV antibiotic launched in US history. In addition to global management training at INSEAD, Jonathan earned an S.M. in Health Policy & Management from Harvard University, and graduated from Trinity College with a Bachelor of Science degree in Neuroscience.

Education

Undergraduate: Bachelor of Science in Neuroscience, Trinity College

Graduate: S.M. in Health Policy & Management, Harvard University

Pierre Jacquet, M.D., Ph.D. is a Managing Director and Vice Chairman of L.E.K. Consulting’s Healthcare practice. Dr. Jacquet has served in a variety of leadership roles for L.E.K., including the firm’s Global Head, Healthcare Practice, Global Leadership Team, the Americas management committee, and various partner operating committees.

Dr. Jacquet has spent more than two decades focused on corporate strategy consulting, merger and acquisition advisory services, and value management, both domestically and internationally. Dr. Jacquet worked with Arthur D. Little as a manager of its pharmaceutical practice and performed business development for Genzyme. During his medical career, he was a Fellow at the Washington Cancer Institute, where he authored over 40 publications and presentations.

Dr. Jacquet is a Director of Exact Sciences, on the Advisory Board of Paragon Biosciences and Life Science Cares, and previously served as a Director of Osprey Pharmaceuticals and T2C2 Ventures. Dr. Jacquet was one of Consulting magazine’s Top 25 Consultants for Excellence in Healthcare; the award recognizes the most influential consultants making the greatest impact within the industry.

Dr. Jacquet earned a Master of Business Administration from the Darden Graduate School at the University of Virginia, was awarded a Doctor of Medicine with high distinction, and a Doctor of Philosophy in biomedical sciences from the University of Liège in Belgium.

Education       

Graduate: Master of Business Administration, Darden Graduate School at University of Virginia - Doctorate of Philosophy, University of Liège, Belgium – Doctor of Medicine, University of Liège, Belgium